Abstract 164: Evaluation of Clinical and Social Factors for Patients Taking Very Low Dose of Beta Blockers for Systolic Heart Failure [Session Title: Poster Session AM]

Conclusions: This study will help enable cardiovascular clinicians to realize that although the use of BBs for SHF has improved dramatically since Get With The Guidelines; there is still marked underdosing of approved BB and inappropriate use of non-approved BB. We are unable to explain this practice based on the clinical and social factors that may have led to underdosing of BB. We found the mean dose of BBs to be 25% or less of TD in 71% (117 of 164) patients on approved BBs and only 18% (19 of 105) of these patients had SR <70bpm. Inappropriate dosing of BBs could potentially be responsible for worsening outcomes and possible overutilization of ivabradine.

Source: Circulation: Cardiovascular Quality and Outcomes - April 5, 2018 Category: Cardiology Authors: Memon, A., Sharma, P., Gilbert, J., Pettyjohn, E., Whelan, M., Nyamndi, B., Kemper, S., Carter, W. Tags: Session Title: Poster Session AM Source Type: research